These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32182485)

  • 1. Clozapine in bipolar disorder: A systematic review and meta-analysis.
    Delgado A; Velosa J; Zhang J; Dursun SM; Kapczinski F; de Azevedo Cardoso T
    J Psychiatr Res; 2020 Jun; 125():21-27. PubMed ID: 32182485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
    Masuda T; Misawa F; Takase M; Kane JM; Correll CU
    JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment.
    Mahmood T; Devlin M; Silverstone T
    Aust N Z J Psychiatry; 1997 Jun; 31(3):424-6. PubMed ID: 9226089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine for treatment-resistant bipolar disorder: a systematic review.
    Li XB; Tang YL; Wang CY; de Leon J
    Bipolar Disord; 2015 May; 17(3):235-47. PubMed ID: 25346322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic drug side effect issues in bipolar manic patients.
    Zarate CA
    J Clin Psychiatry; 2000; 61 Suppl 8():52-61; discussion 62-3. PubMed ID: 10811244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
    Muralidharan K; Ali M; Silveira LE; Bond DJ; Fountoulakis KN; Lam RW; Yatham LN
    J Affect Disord; 2013 Sep; 150(2):408-14. PubMed ID: 23735211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.
    Wagner E; Siafis S; Fernando P; Falkai P; Honer WG; Röh A; Siskind D; Leucht S; Hasan A
    Transl Psychiatry; 2021 Sep; 11(1):487. PubMed ID: 34552059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid clozapine titration in treatment-refractory bipolar disorder.
    Ifteni P; Correll CU; Nielsen J; Burtea V; Kane JM; Manu P
    J Affect Disord; 2014 Sep; 166():168-72. PubMed ID: 25012427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
    Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
    Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis.
    Shirazi A; Stubbs B; Gomez L; Moore S; Gaughran F; Flanagan RJ; MacCabe JH; Lally J
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C; Sachs GS; Ghaemi SN
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy.
    Barak Y; Wittenberg N; Naor S; Kutzuk D; Weizman A
    Compr Psychiatry; 1999; 40(4):320-5. PubMed ID: 10428193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of clozapine may stabilize treatment-resistant bipolar patients.
    Fehr BS; Ozcan ME; Suppes T
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):10-4. PubMed ID: 15538596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticonvulsants and antipsychotics in the treatment of bipolar disorder].
    Moreno RA; Moreno DH; Soares MB; Ratzke R
    Braz J Psychiatry; 2004 Oct; 26 Suppl 3():37-43. PubMed ID: 15597138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials.
    Fornaro M; Carvalho AF; Fusco A; Anastasia A; Solmi M; Berk M; Sim K; Vieta E; de Bartolomeis A
    J Affect Disord; 2020 Nov; 276():970-983. PubMed ID: 32750614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.